Another experiment showed that, in order to resist Adriamycin-induced DNA damage, MLL3/4 collaborated with the ASCOM complex to increase the methylation level of H3K4, activate p53, increase the expression of endogenous p53 target genes, and participate in the tumor-suppressing pathway of p53 (45). This evidence concerns the gene KMT2C and neoplasm.